Lupus anticoagulants and antiphospholipid antibodies
Lupus anticoagulants are antibodies against substances in the lining of cells. These substances prevent blood clotting in a test tube. They are called phospholipids.
People with antibodies to phospholipids (aPL) may have a very high risk of forming blood clots. In spite of the name anticoagulant, there is no increased risk of bleeding.
Blood clots - lupus anticoagulants; DVT - anticoagulants
Most often, lupus anticoagulants and aPL are found in people with diseases such as systemic lupus erythematosus (SLE).
Lupus anticoagulants and aPL may also occur if:
- You take medicines such as phenothiazines, phenytoin, hydralazine, quinine, or the antibiotic amoxicillin.
- You have a condition such as inflammatory bowel disease (Crohn disease and ulcerative colitis), infections, or certain kinds of tumors.
Some people have no risk factors for this condition.
You may not have any symptoms even though you have the antibodies. Symptoms that may occur include:
Lupus anticoagulant tests may be done. These are blood clotting tests. The antiphospholipid antibodies (aPL) cause the tests to be abnormal in the laboratory.
Types of clotting tests may include:
- Activated partial thromboplastin time (aPTT)
- Russell viper venom time
- Thromboplastin inhibition test
Tests for antiphospholipid antibodies (aPL) may include:
- Anticardiolipin antibody tests
- Antibodies to beta-2-glypoprotein I (Beta2-GPI)
Your health care provider may check for antiphospholipid antibody syndrome (APS) if:
- A blood clot is found.
- Repeated miscarriages occur.
- You have positive tests for aPL or the lupus anticoagulant.
The positive tests need to be confirmed after 12 weeks. If you have a positive test without other indications of the disease, you will not have the diagnosis of APS.
LUPUS ANTICOAGULANT OR APL
Often, you will not need treatment if you do not have symptoms or if you have never had a blood clot in the past.
Take the following steps to help prevent blood clots from forming:
- Avoid most birth control pills or hormone treatments for menopause (women).
- DO NOT smoke or use other tobacco products.
- Get up and move around during long plane flights or other times when you have to sit or lie down for extended periods.
- Move your ankles up and down when you cannot move around.
You will be prescribed blood-thinning medicines (such as heparin and warfarin) to help prevent blood clots:
- After surgery
- After a bone fracture
- With active cancer
- When you need to set or lie down for long periods of time, such as during a hospital stay or recovering at home
You may also need to take blood thinners for 3 to 4 weeks after surgery to lower your risk of blood clots.
ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS)
In general, you will need long-term treatment with a blood thinner for a long time if you have the APS. Initial treatment may be heparin, either unfractionated or low-molecular heparin. These medicines are given by injection.
In most cases, warfarin (Coumadin), which is given by mouth, is then started. It is necessary to monitor the level of anticoagulation frequently. This is most often done using the INR test.
If you have APS and become pregnant, you will need to be followed closely by a provider expert in this condition. You will not take warfarin during pregnancy, but will be given low-molecular weight heparin instead.
If you have SLE and APS your provider will also recommend that you take hydroxychloroquine.
Most of the time, outcome is good with proper treatment. Some people may have blood clots that are hard to control with treatments. Symptoms may recur.
Call your provider if you notice symptoms of a blood clot, such as:
- Swelling or redness in the leg
- Shortness of breath
- Pain, numbness, and pale skin color in an arm or leg
Also talk to your provider if you have repeated loss of pregnancy (miscarriage).
Erkan D, Salmon JE, Lockshin MD. Anti-phospholipid syndrome. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, eds. Kelley and Firestein's Textbook of Rheumatology. 10th ed. Philadelphia, PA: Elsevier; 2017:chap 82.
Khamashta MA, Amigo M-C. Antiphospholipid syndrome: overview of pathogenesis, diagnosis, and management. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 6th ed. Philadelphia, PA: Elsevier Mosby; 2015:chap 139.
Review Date: 2/8/2017
Reviewed By: Gordon A. Starkebaum, MD, Professor of Medicine, Division of Rheumatology, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.